Holen Sie sich die Stockscreener-App
1.54
7.23%
-0.12
Handel nachbörslich:
1.51
-0.03
-1.95%
Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud - GlobeNewswire
Allergic Conjunctivitis Clinical Trials Landscape 2026: Regulatory Approvals (FDA, EMA, PMDA), Drug Innovations, Mechanisms, Routes of Administration, IND/NDA Progress, and Companies | DelveInsight - Barchart.com
Aldeyra Therapeutics Faces Class Action Lawsuit Over Drug Trial Issues - National Today
ADLX Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
ADLX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Aldeyra Therapeutics, Inc. Class Action Lawsuit - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aldeyra - GlobeNewswire
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - The Norfolk Daily News
ALDX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Connect - ACCESS Newswire
Shareholders who lost money in Aldeyra Therapeutics, Inc. - GlobeNewswire
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Connect - ACCESS Newswire
2026-04-03 | ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ALDX | Press Release - Stockhouse
ROSEN Attorneys Encourage Aldeyra Therapeutics Investors to Secure Counsel - National Today
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ADLX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Filed Against Aldeyra Therapeutics, Inc. - Finansavisen
ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) ... - Bluefield Daily Telegraph
ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming DeadlinesALDX - PR Newswire
ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
ALDX SEC FilingsAldeyra Therapeutics Inc 10-K, 10-Q, 8-K Forms - stocktitan.net
BTIG Maintains ALDX (Aldeyra Therapeutics) at Buy on Mar 17, 2026 - Meyka
Aldeyra Therapeutics, Inc. 8-K SEC Filing April 2026 – Company Information, Address, and Trading Details - Minichart
ALDX Forecast, Price Target & Analyst Ratings | ALDEYRA THERAPEUTICS INC (NASDAQ:ALDX) - ChartMill
Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire
Aldeyra Therapeutics pays off $15 million outstanding borrowings, terminates Hercules credit facilitySEC filing - marketscreener.com
Aldeyra Therapeutics repays $15 million Hercules loan and ends credit facility By Investing.com - Investing.com South Africa
Aldeyra Therapeutics Pays Off $15 Million Outstanding Borrowings, Terminates Hercules Credit FacilitySEC Filing - TradingView
Aldeyra Therapeutics repays $15 million Hercules loan and ends credit facility - Investing.com Canada
Aldeyra Repays Hercules Loan, Boosting Financial Flexibility - TipRanks
Aldeyra pays off $15M loan, terminates Hercules credit facility - TradingView
Aldeyra (NASDAQ: ALDX) pays off $15M Hercules loan, extends runway - stocktitan.net
Aldeyra Therapeutics, Inc. Pays Off $15 Million Outstanding Borrowings and Terminates Hercules Credit Facility - marketscreener.com
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - natlawreview.com
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Malaysian Reserve
INVESTOR ALERT: Securities Class Action Filed Against Aldeyra Therapeutics – Investors Encouraged to Contact Kirby McInerney LLP - Business Wire
ALDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therap - GuruFocus
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
ALDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - 巴士的報
Aldeyra (NASDAQ: ALDX) grants CEO 1.88M options and bonus units - stocktitan.net
Aldeyra Therapeutics Sued for Securities Fraud - National Today
Lawsuit Filed Against Aldeyra Therapeutics Over Clinical Trial Inconsistencies - National Today
Portnoy Law Firm Announces Class Action on Behalf of Aldeyra Therapeutics, Inc. Investors - GlobeNewswire
Class Action Lawsuit Filed Against Aldeyra Therapeutics - National Today
2026-03-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation | NDAQ:ALDX | Press Release - Stockhouse
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
$ALDX Lawsuit: Aldeyra Therapeutics, Inc. Sued for Securities Fraud; Investors Should Contact ... - Bluefield Daily Telegraph
$ALDX Lawsuit: Aldeyra Therapeutics, Inc. Sued for - GlobeNewswire
Robbins LLP Informs Investors of Aldeyra Therapeutics Class Action - National Today
Investor Notice: Robbins LLP Informs Investors of the Aldeyra Therapeutics, Inc. Class Action - marketscreener.com
Rosen Law Firm Files Securities Class Action Lawsuit Against Aldeyra Therapeutics - National Today
ROSEN Law Firm Encourages Aldeyra Therapeutics Investors to Seek Legal Counsel - National Today
Rosen Law Firm Files Securities Class Action Against Aldeyra Therapeutics - National Today
Value Recap: Can Aldeyra Therapeutics Inc maintain sales growth2026 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
ROSEN, LEADING INVESTOR COUNSEL, Encourages Hercules Capital, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra - GlobeNewswire
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Aldeyra Therapeutics, Inc. Investors – ALDX - The AI Journal
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):